Title : Therapeutic strategies in childhood multiple sclerosis.

Pub. Date : 2010 Jul

PMID : 21179613






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Cyclophosphamide and natalizumab could be offered as second-line treatment in patients with a poor response to IFNB or GA. Cyclophosphamide interferon beta 1 Homo sapiens